DK62089A - Antiviral blanding - Google Patents

Antiviral blanding

Info

Publication number
DK62089A
DK62089A DK062089A DK62089A DK62089A DK 62089 A DK62089 A DK 62089A DK 062089 A DK062089 A DK 062089A DK 62089 A DK62089 A DK 62089A DK 62089 A DK62089 A DK 62089A
Authority
DK
Denmark
Prior art keywords
alpha
antiviral
mixing
component
interferon
Prior art date
Application number
DK062089A
Other languages
Danish (da)
English (en)
Other versions
DK62089D0 (da
Inventor
J David Gangemi
Heinz-Kurt Hochkeppel
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK62089D0 publication Critical patent/DK62089D0/da
Publication of DK62089A publication Critical patent/DK62089A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK062089A 1988-02-13 1989-02-10 Antiviral blanding DK62089A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888803365A GB8803365D0 (en) 1988-02-13 1988-02-13 Antiviral combination

Publications (2)

Publication Number Publication Date
DK62089D0 DK62089D0 (da) 1989-02-10
DK62089A true DK62089A (da) 1989-08-14

Family

ID=10631664

Family Applications (1)

Application Number Title Priority Date Filing Date
DK062089A DK62089A (da) 1988-02-13 1989-02-10 Antiviral blanding

Country Status (15)

Country Link
US (1) US5137720A (de)
EP (1) EP0329609B1 (de)
JP (1) JP2781191B2 (de)
KR (1) KR0131077B1 (de)
AT (1) ATE99953T1 (de)
AU (1) AU623876B2 (de)
CA (1) CA1336578C (de)
DE (1) DE68912155T2 (de)
DK (1) DK62089A (de)
GB (1) GB8803365D0 (de)
IE (1) IE63493B1 (de)
IL (1) IL89248A (de)
NZ (1) NZ227944A (de)
PH (1) PH26919A (de)
ZA (1) ZA891053B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW218846B (de) * 1992-04-07 1994-01-11 Ciba Geigy
FR2702659B1 (fr) * 1993-03-19 1995-08-25 Vacsyn Sa Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine.
DK0689449T3 (da) * 1993-03-19 2003-03-03 Vacsyn Sa Præparater til anvendelse i humanterapi, kendetegnet ved kombination af et muramylpeptid med en cytokin
US5461512A (en) * 1993-11-30 1995-10-24 Eastman Kodak Company Zoom camera lens having three moving groups
DK0708085T3 (da) * 1994-10-19 2002-11-11 Novartis Ag Antivirale ethere af aspartatproteasesubstrat-isostere
US5786214A (en) * 1994-12-15 1998-07-28 Spinal Cord Society pH-sensitive immunoliposomes and method of gene delivery to the mammalian central nervous system
CZ304942B6 (cs) 2000-03-31 2015-02-04 Purdue Research Foundation Léčivo pro zvyšování specifické eliminace populace tumorových buněk a farmaceutický prostředek obsahující konjugát fosfát-FITC nebo fosfát-dinitrofenyl
CA2461877A1 (en) * 2001-09-28 2003-04-10 Purdue Research Foundation Method of treatment using ligand-immunogen conjugates
US20030180348A1 (en) * 2002-03-22 2003-09-25 Levinson R. Saul Transcellular drug delivery system
WO2007092299A2 (en) * 2006-02-03 2007-08-16 Purdue Research Foundation Targeted conjugates and radiation
US7625555B2 (en) 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
US20080317836A1 (en) * 2007-06-19 2008-12-25 Discovery Partners Llc Topical compositions for anti-aging skin treatment
RU2488405C1 (ru) * 2012-07-17 2013-07-27 Илья Александрович Марков Лекарственное средство, обладающее противовирусным, противовоспалительным, иммуномодулирующим и обезболивающим действием, для местного и наружного применения - герпферон 2
KR101658048B1 (ko) 2014-06-25 2016-09-20 한국생명공학연구원 포스파티딜콜린 합성경로 관여 물질을 포함하는 항바이러스용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS616000A (ja) * 1984-06-21 1986-01-11 木下　菊巳 回転色合せ盤
ATE78262T1 (de) * 1985-06-11 1992-08-15 Ciba Geigy Ag Hybrid-interferone.
US4774085A (en) * 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
AU603820B2 (en) * 1986-08-13 1990-11-29 Takeda Chemical Industries Ltd. Antitumor agent

Also Published As

Publication number Publication date
EP0329609A2 (de) 1989-08-23
IE890435L (en) 1989-08-13
DE68912155T2 (de) 1994-06-16
KR0131077B1 (ko) 1998-04-17
EP0329609B1 (de) 1994-01-12
CA1336578C (en) 1995-08-08
NZ227944A (en) 1991-08-27
PH26919A (en) 1992-12-03
ZA891053B (en) 1989-10-25
EP0329609A3 (en) 1990-05-16
GB8803365D0 (en) 1988-03-16
IL89248A (en) 1994-01-25
JPH021410A (ja) 1990-01-05
AU2894389A (en) 1989-08-17
ATE99953T1 (de) 1994-01-15
IE63493B1 (en) 1995-05-03
JP2781191B2 (ja) 1998-07-30
DK62089D0 (da) 1989-02-10
US5137720A (en) 1992-08-11
AU623876B2 (en) 1992-05-28
IL89248A0 (en) 1989-09-10
KR890012670A (ko) 1989-09-18
DE68912155D1 (de) 1994-02-24

Similar Documents

Publication Publication Date Title
NZ215939A (en) Phosphonyl methoxyadenine antiviral compositions
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
DK62089A (da) Antiviral blanding
FI852626A0 (fi) Menetelmä ihmisen tuumorinekroositekijän valmistamiseksi ja sitä koodaava DNA
DE3776946D1 (de) Nasale verabreichung von arzneimitteln.
NZ226005A (en) Covalent conjugates of a human cytokine and a human immunoglobulin, processes for their manufacture and pharmaceutical compositions thereof
FI862011A0 (fi) Terapeutiska nukleosider.
DE3855099D1 (de) Nucleoside zur Verwendung für die Therapie
DE3667605D1 (de) Windel zur verhuetung von wundliegen.
EP0270690A4 (de) Arzneimittel zur behandlung und prophylaxe von leber- und nierenkrankheiten.
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
EP0241889A3 (de) Verwendung von TNF zur Herstellung von Arzneimitteln
DE3572441D1 (en) Use of interferon gamma (ifn-gamma) for the production of preparations for treating rheumatic diseases
ES2037807T3 (es) Medicamentos que contienen en combinacion interferon y 1-desoxi-piperidinosas, procedimiento para su fabricacion y su aplicacion.
AU7336687A (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
ZA9410381B (en) Use of Bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases
DE3883754D1 (de) Mittel zur prophylaxe und behandlung von viralen infektionskrankheiten.
DE3770133D1 (de) Arzneimittel zur behandlung und prophylaxe von leber- und nierenkrankheiten.
RO92916A2 (ro) Medicament biostimulator destinat tratamentului insuficientelor medulare si hepatitelor virale

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment